CA3018945A1 - Compositions, composes bolaamphiphiles, et leurs utilisations - Google Patents

Compositions, composes bolaamphiphiles, et leurs utilisations Download PDF

Info

Publication number
CA3018945A1
CA3018945A1 CA3018945A CA3018945A CA3018945A1 CA 3018945 A1 CA3018945 A1 CA 3018945A1 CA 3018945 A CA3018945 A CA 3018945A CA 3018945 A CA3018945 A CA 3018945A CA 3018945 A1 CA3018945 A1 CA 3018945A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
compound
glh
bolaamphiphilic
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3018945A
Other languages
English (en)
Inventor
Charles Linder
Eliahu Heldman
Sarina Grinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAUREN SCIENCES LLC
Original Assignee
LAUREN SCIENCES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAUREN SCIENCES LLC filed Critical LAUREN SCIENCES LLC
Publication of CA3018945A1 publication Critical patent/CA3018945A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention porte sur des composés bolaamphiphiles de formule (I) dans laquelle HG1, HG2 et L1 sont tels que définis dans la description. Les composés bolaamphiphiles divulgués et les compositions pharmaceutiques les comprenant sont utiles pour délivrer GDNF ou NGF dans un cerveau d'animal ou d'humain.
CA3018945A 2015-04-16 2016-04-15 Compositions, composes bolaamphiphiles, et leurs utilisations Abandoned CA3018945A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562148511P 2015-04-16 2015-04-16
US62/148,511 2015-04-16
US201562258773P 2015-11-23 2015-11-23
US62/258,773 2015-11-23
PCT/US2016/027726 WO2016168580A1 (fr) 2015-04-16 2016-04-15 Compositions, composés bolaamphiphiles, et leurs utilisations

Publications (1)

Publication Number Publication Date
CA3018945A1 true CA3018945A1 (fr) 2016-10-20

Family

ID=57126121

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3018945A Abandoned CA3018945A1 (fr) 2015-04-16 2016-04-15 Compositions, composes bolaamphiphiles, et leurs utilisations

Country Status (5)

Country Link
EP (1) EP3283060A4 (fr)
AU (1) AU2016248992A1 (fr)
CA (1) CA3018945A1 (fr)
IL (1) IL255042B (fr)
WO (1) WO2016168580A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022087175A1 (fr) * 2020-10-21 2022-04-28 University Of San Diego Bolaamphiphiles multivalents à base de terpène destinés à l'introduction de gènes
IL302607A (en) * 2020-11-03 2023-07-01 Onconano Medicine Inc pH-dependent therapeutic preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642803B2 (en) * 2009-05-04 2017-05-09 Ben-Gurion University Of The Negev Research And Development Authority Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
AU2013312909C1 (en) * 2012-09-04 2018-02-08 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof
WO2014039501A1 (fr) * 2012-09-04 2014-03-13 Lauren Sciences Llc Composés bolaamphiphiles, compositions et leurs utilisations
AU2013312819A1 (en) * 2012-09-04 2015-03-26 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof

Also Published As

Publication number Publication date
IL255042B (en) 2022-04-01
AU2016248992A1 (en) 2017-12-07
IL255042A0 (en) 2017-12-31
EP3283060A1 (fr) 2018-02-21
WO2016168580A1 (fr) 2016-10-20
EP3283060A4 (fr) 2018-12-19

Similar Documents

Publication Publication Date Title
US20190381137A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
AU2022200494A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
AU2013312909B2 (en) Bolaamphiphilic compounds, compositions and uses thereof
CA3018945A1 (fr) Compositions, composes bolaamphiphiles, et leurs utilisations
US20150110875A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
US20220072098A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
US11304964B2 (en) Bolaamphiphilic compounds, compositions and uses thereof
AU2018202949B2 (en) Bolaamphiphilic compounds, compositions and uses thereof
AU2013312910B2 (en) Bolaamphiphilic compounds, compositions and uses thereof
US20220249539A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
US20180021368A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
CA2883632A1 (fr) Composes bolaamphiphiles, compositions et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210412

EEER Examination request

Effective date: 20210412

EEER Examination request

Effective date: 20210412

EEER Examination request

Effective date: 20210412

EEER Examination request

Effective date: 20210412

FZDE Discontinued

Effective date: 20231211